{"entity":{"type":"insider","cik":"0001495411","url":"/insider/0001495411","json_url":"/insider/0001495411.json","name":"Goldan Keith A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":15,"first":"2015-08-11","last":"2026-06-02","span_basis":"filed_date"},"name_variants":[{"name":"Goldan Keith A.","source":"filing","n_filings":15,"first_seen":"2015-08-11","last_seen":"2026-06-02"}],"transactions":[{"id":6088629,"accession":"0001193125-26-253603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-253603","line_url":"/filing/0001193125-26-253603#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1177.0,"shares_display":"1,177","price_per_share":18.99,"price_display":"18.99","price_state":"stated","total_value":22351.23,"total_display":"22,351.23","total_whole":"22,351","shares_owned_after":139252.0,"shares_owned_after_display":"139,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":5978476,"accession":"0001193125-26-043813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-043813","line_url":"/filing/0001193125-26-043813#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3410.0,"shares_display":"3,410","price_per_share":21.028,"price_display":"21.03","price_state":"stated","total_value":71705.48,"total_display":"71,705.48","total_whole":"71,705","shares_owned_after":140429.0,"shares_owned_after_display":"140,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-10","scope":"insider"},{"id":6228607,"accession":"0001193125-26-041497","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-041497","line_url":"/filing/0001193125-26-041497#line-4","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2082.0,"shares_display":"2,082","price_per_share":20.62,"price_display":"20.62","price_state":"stated","total_value":42930.84,"total_display":"42,930.84","total_whole":"42,931","shares_owned_after":143839.0,"shares_owned_after_display":"143,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-06","scope":"insider"},{"id":4313960,"accession":"0000950170-25-096948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-096948","line_url":"/filing/0000950170-25-096948#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1296.0,"shares_display":"1,296","price_per_share":9.285,"price_display":"9.28","price_state":"stated","total_value":12033.36,"total_display":"12,033.36","total_whole":"12,033","shares_owned_after":92450.0,"shares_owned_after_display":"92,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-07-18","scope":"insider"},{"id":4341407,"accession":"0000950170-25-074304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-074304","line_url":"/filing/0000950170-25-074304#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":93746.0,"shares_owned_after_display":"93,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-19","scope":"insider"},{"id":4340065,"accession":"0000950170-25-019005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-019005","line_url":"/filing/0000950170-25-019005#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3777.0,"shares_display":"3,777","price_per_share":15.504,"price_display":"15.50","price_state":"stated","total_value":58558.608,"total_display":"58,558.61","total_whole":"58,559","shares_owned_after":90746.0,"shares_owned_after_display":"90,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":3258691,"accession":"0001562180-24-005118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-005118","line_url":"/filing/0001562180-24-005118#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":20.0298,"price_display":"20.03","price_state":"stated","total_value":25037.25,"total_display":"25,037.25","total_whole":"25,037","shares_owned_after":52623.0,"shares_owned_after_display":"52,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-17","scope":"insider"},{"id":8302513,"accession":"0001562180-23-005152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-005152","line_url":"/filing/0001562180-23-005152#line-1","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":577.0,"shares_display":"577","price_per_share":22.31,"price_display":"22.31","price_state":"stated","total_value":12872.87,"total_display":"12,872.87","total_whole":"12,873","shares_owned_after":2628.0,"shares_owned_after_display":"2,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":6246524,"accession":"0001494650-22-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494650-22-000029","line_url":"/filing/0001494650-22-000029#line-1","is_derivative":false,"issuer_cik":"0001494650","issuer_name":"OptiNose, Inc.","issuer_ticker":"OPTN","issuer_name_source":null,"issuer_url":"/issuer/0001494650","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4617.0,"shares_display":"4,617","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":9741.87,"total_display":"9,741.87","total_whole":"9,742","shares_owned_after":141726.0,"shares_owned_after_display":"141,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-17","scope":"insider"},{"id":5435102,"accession":"0001494650-21-000155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494650-21-000155","line_url":"/filing/0001494650-21-000155#line-1","is_derivative":false,"issuer_cik":"0001494650","issuer_name":"OptiNose, Inc.","issuer_ticker":"OPTN","issuer_name_source":null,"issuer_url":"/issuer/0001494650","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":580.0,"shares_display":"580","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":951.2,"total_display":"951.20","total_whole":"951","shares_owned_after":89613.0,"shares_owned_after_display":"89,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-17","scope":"insider"},{"id":4696497,"accession":"0001494650-21-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494650-21-000108","line_url":"/filing/0001494650-21-000108#line-1","is_derivative":false,"issuer_cik":"0001494650","issuer_name":"OptiNose, Inc.","issuer_ticker":"OPTN","issuer_name_source":null,"issuer_url":"/issuer/0001494650","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":578.0,"shares_display":"578","price_per_share":2.789,"price_display":"2.79","price_state":"stated","total_value":1612.042,"total_display":"1,612.04","total_whole":"1,612","shares_owned_after":90193.0,"shares_owned_after_display":"90,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-17","scope":"insider"},{"id":4320901,"accession":"0001494650-21-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494650-21-000076","line_url":"/filing/0001494650-21-000076#line-1","is_derivative":false,"issuer_cik":"0001494650","issuer_name":"OptiNose, Inc.","issuer_ticker":"OPTN","issuer_name_source":null,"issuer_url":"/issuer/0001494650","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":576.0,"shares_display":"576","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":2148.48,"total_display":"2,148.48","total_whole":"2,148","shares_owned_after":90771.0,"shares_owned_after_display":"90,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-17","scope":"insider"},{"id":4990728,"accession":"0001494650-21-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494650-21-000041","line_url":"/filing/0001494650-21-000041#line-1","is_derivative":false,"issuer_cik":"0001494650","issuer_name":"OptiNose, Inc.","issuer_ticker":"OPTN","issuer_name_source":null,"issuer_url":"/issuer/0001494650","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2304.0,"shares_display":"2,304","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":9031.68,"total_display":"9,031.68","total_whole":"9,032","shares_owned_after":91347.0,"shares_owned_after_display":"91,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":2943341,"accession":"0001494650-20-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494650-20-000125","line_url":"/filing/0001494650-20-000125#line-1","is_derivative":false,"issuer_cik":"0001494650","issuer_name":"OptiNose, Inc.","issuer_ticker":"OPTN","issuer_name_source":null,"issuer_url":"/issuer/0001494650","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.897,"price_display":"3.90","price_state":"stated","total_value":9742.5,"total_display":"9,742.50","total_whole":"9,743","shares_owned_after":9751.0,"shares_owned_after_display":"9,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":8816015,"accession":"0000357097-15-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000357097-15-000092","line_url":"/filing/0000357097-15-000092#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001495411","owner_name":"Goldan Keith A.","owner_display_name":"Goldan Keith A.","owner_url":"/insider/0001495411","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":12660.0,"total_display":"12,660.00","total_whole":"12,660","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001395937","name":"Syndax Pharmaceuticals Inc","url":"/issuer/0001395937","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2023-06-14","last_seen":"2026-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001494650","name":"OptiNose, Inc.","url":"/issuer/0001494650","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2020-09-23","last_seen":"2022-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000357097","name":"Fibrocell Science, Inc.","url":"/issuer/0000357097","role":"Officer (SVP and CFO)","n_filings":1,"first_seen":"2015-08-11","last_seen":"2015-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001495411","retrieved_at":"2026-08-26T06:21:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}